Recommended pre-submission checks
Powered by 

Topics Covered on Papillomavirus Research
Papillomavirus Research Journal Specifications
Indexed in the following public directories
DOAJ
| Overview | |
| Publisher | Elsevier |
| Language | English |
| Article Processing Charges | USD 900 |
| Publication Time | 14 |
| Editorial Review Process | Blind peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | International Papillomavirus Society |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors |
View less
Planning to publish in Papillomavirus Research ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Papillomavirus Research
Targeting EBV-associated gastric cancer by lytic induction therapy with nanatinostat.
- 27 Jun 2026
- Tumour virus research
30-hydroxygambogic acid activates overlapping and independent apoptotic pathways in HPV positive and HPV negative oral cancer cells.
- 1 Jun 2026
- Tumour virus research
HPV18E6 and CDK5 virus-host interaction is a prospective therapeutic target for HPV-positive cervical cancer.
- 1 Jun 2026
- Tumour virus research
Oncolytic virus hijacks GOT1 and pyrimidinosomes to fuel pyrimidine synthesis for replication in tumor cells.
- 1 Jun 2026
- Tumour virus research
Susceptibility of naturally human papillomavirus type 16 major capsid protein L1 variants to vaccines and predictions of future evolutionary trends.
- 1 Jun 2026
- Tumour virus research
PRMT5–mediated symmetric dimethylation of SHBs at Arg169 stabilizes SHBs and promotes angiogenesis and tumor growth
- 26 Mar 2026
- Tumour Virus Research
Targeting EBV-associated gastric cancer by lytic induction therapy with nanatinostat.
- 27 Jun 2026
- Tumour virus research
30-hydroxygambogic acid activates overlapping and independent apoptotic pathways in HPV positive and HPV negative oral cancer cells.
- 1 Jun 2026
- Tumour virus research
HPV18E6 and CDK5 virus-host interaction is a prospective therapeutic target for HPV-positive cervical cancer.
- 1 Jun 2026
- Tumour virus research
Oncolytic virus hijacks GOT1 and pyrimidinosomes to fuel pyrimidine synthesis for replication in tumor cells.
- 1 Jun 2026
- Tumour virus research
Susceptibility of naturally human papillomavirus type 16 major capsid protein L1 variants to vaccines and predictions of future evolutionary trends.
- 1 Jun 2026
- Tumour virus research
PRMT5–mediated symmetric dimethylation of SHBs at Arg169 stabilizes SHBs and promotes angiogenesis and tumor growth
- 26 Mar 2026
- Tumour Virus Research